Nitrosamine Impurities-Aug 2023 NDSRIs Limit USFDA Guidance | Control of Nitrosamine Guidance Feb-21

Length 44:51 • 18.4K Views • 1 year ago
ProfTalks 📃 My History
Share

Video Terkait

Webinar: Nitrosamines in Medicinal Products – Assessing the Risks
42:53
Webinar: Nitrosamines in Medicinal Products – Assessing the Risks
11.9K
4 years ago
Nitrosamines Issue - A Regulatory Overview Scientific Webinar 2024
50:02
Nitrosamines Issue - A Regulatory Overview Scientific Webinar 2024
449
9 months ago
USFDA Inspections: Overview | Difference between USFDA Inspection & Other Authority Inspections
20:52
USFDA Inspections: Overview | Difference between USFDA Inspection & Other Authority Inspections
1.1K
1 year ago
PCM Control Strategy Material Characterization
1:00:46
PCM Control Strategy Material Characterization
12
6 days ago
Nitrosamine analysis in different sartan and metformin drug formulations by LC-MS/MS
42:48
Nitrosamine analysis in different sartan and metformin drug formulations by LC-MS/MS
2.3K
3 years ago
ICH Q3D Guidance for Elemental Impurities | Example for calculating | Permitted Daily Dose (PDE)
34:21
ICH Q3D Guidance for Elemental Impurities | Example for calculating | Permitted Daily Dose (PDE)
12.1K
2 years ago
How to calculate limit for Nitrosamines in ppm as per USFDA guideline
9:24
How to calculate limit for Nitrosamines in ppm as per USFDA guideline
13.7K
3 years ago
Regulatory Considerations for Impurity Qualification: ICH Q3A/Q3C/Q3D, RLD & MDD
28:12
Regulatory Considerations for Impurity Qualification: ICH Q3A/Q3C/Q3D, RLD & MDD
10.2K
3 years ago
Nitrosamines impurities by M. Filancia (EMA)
17:19
Nitrosamines impurities by M. Filancia (EMA)
2.9K
2 years ago
How to Define Limit For Newly Identified Nitrosamine Impurity?
17:16
How to Define Limit For Newly Identified Nitrosamine Impurity?
8.5K
2 years ago
Quality Metrics Data Submission USFDA Guidance| USFDA Guidelines |
30:33
Quality Metrics Data Submission USFDA Guidance| USFDA Guidelines |
1.3K
1 year ago
Zydus Vadodara Warning Letter Sep 2024 | Learning through USFDA Warning Letters
12:30
Zydus Vadodara Warning Letter Sep 2024 | Learning through USFDA Warning Letters
448
2 months ago
Applying Expert Knowledge for ICH M7 Impurity Classification - Session 1
1:00:09
Applying Expert Knowledge for ICH M7 Impurity Classification - Session 1
7.9K
4 years ago
INDAH YASTAMI FULL ALBUM - AIR MATA DI HARI PERSANDINGANMU - ASMARA || COVER AKUSTIK TERBAIK 2024
54:58
INDAH YASTAMI FULL ALBUM - AIR MATA DI HARI PERSANDINGANMU - ASMARA || COVER AKUSTIK TERBAIK 2024
1.2M
5 months ago
ICH M7(R1) – Chemistry and Manufacturing Control (CMC) Perspective on Hazard Assessment
20:33
ICH M7(R1) – Chemistry and Manufacturing Control (CMC) Perspective on Hazard Assessment
6.6K
3 years ago
Residual Solvents and Elemental Impurities: Classification & Exposure Limits as per ICH Q3C AND Q3D
20:38
Residual Solvents and Elemental Impurities: Classification & Exposure Limits as per ICH Q3C AND Q3D
12.1K
1 year ago
How to Decide the Need of Testing Nitrosamine Impurities into Pharmaceuticals?
8:35
How to Decide the Need of Testing Nitrosamine Impurities into Pharmaceuticals?
15.6K
2 years ago
ICH Q3C Guidance for Residual Solvents | Class of Residual Solvents | PDE Values of Residual Solvent
17:22
ICH Q3C Guidance for Residual Solvents | Class of Residual Solvents | PDE Values of Residual Solvent
4.5K
1 year ago
Quality Risk Management ICH Q9(R1)
1:09:08
Quality Risk Management ICH Q9(R1)
14.3K
1 year ago
Intas Pharma Warning Letter 28 July 2023 | Learning from USFDA Warning Letters | 2023 Warning Letter
19:03
Intas Pharma Warning Letter 28 July 2023 | Learning from USFDA Warning Letters | 2023 Warning Letter
3K
1 year ago